Page last updated: 2024-10-24

cefuroxime and Bronchiolitis, Exudative

cefuroxime has been researched along with Bronchiolitis, Exudative in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"BACKGROUND Bronchiolitis obliterans is the term used to describe a clinical syndrome of irreversible airflow obstruction."5.51Bronchiolitis Obliterans After Cefuroxime-Induced Stevens-Johnson Syndrome. ( Qanash, SA; Shabrawishi, M, 2019)
"BACKGROUND Bronchiolitis obliterans is the term used to describe a clinical syndrome of irreversible airflow obstruction."1.51Bronchiolitis Obliterans After Cefuroxime-Induced Stevens-Johnson Syndrome. ( Qanash, SA; Shabrawishi, M, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shabrawishi, M1
Qanash, SA1

Other Studies

1 other study available for cefuroxime and Bronchiolitis, Exudative

ArticleYear
Bronchiolitis Obliterans After Cefuroxime-Induced Stevens-Johnson Syndrome.
    The American journal of case reports, 2019, Feb-09, Volume: 20

    Topics: Adult; Anti-Bacterial Agents; Bronchiolitis Obliterans; Cefuroxime; Female; Humans; Stevens-Johnson

2019